In contrast, Chung et al. highlighted that high expressions of their derived Sox2 signature were significantly associated with favorable prognosis for overall survival and disease-free survival in patients with HNSCC [49]. This evidence concerns the gene SOX2 and head and neck squamous cell carcinoma.